ライフサイエンスコーパス: Legionnaires' disease

1 gionella pneumophila, the causative agent of Legionnaires disease.

2 an opportunistic human pathogen that causes Legionnaires disease.

3 therefore contribute to the establishment of Legionnaires disease.

4 fection was assessed using a murine model of Legionnaires' disease.

5 umophila is a protozoan parasite that causes Legionnaires' disease.

6 a potentially fatal form of pneumonia named Legionnaires' disease.

7 hila can result in a severe pneumonia called Legionnaires' disease.

8 t to be major factors in the transmission of Legionnaires' disease.

9 in the design of attenuated vaccines against Legionnaires' disease.

10 ronmental bacterium and the leading cause of Legionnaires' disease.

11 o replicate within mammalian cells and cause Legionnaires' disease.

12 ntified unsuspected patients with nosocomial legionnaires' disease.

13 for improved surveillance for travel-related Legionnaires' disease.

14 ost was investigated using a murine model of Legionnaires' disease.

15 c infection caused by Legionella bacteria is Legionnaires' disease.

16 that cause a severe form of pneumonia called Legionnaires' disease.

17 la pneumophila, the major causative agent of Legionnaires' disease.

18 as source of infection resulting in cases of Legionnaires' disease.

19 agent of a severe form of pneumonia known as Legionnaires' disease.

20 acterization of the regional epidemiology of Legionnaires' disease.

21 ssociated with community-acquired sources of Legionnaires' disease.

22 CR is the most sensitive diagnostic tool for Legionnaires' disease.

23 cause of a severe pneumonia in humans called Legionnaires' disease.

24 causative agent of a severe pneumonia called Legionnaires' disease.

25 iological agent of severe pneumonia known as Legionnaires' disease.

26 n that causes sporadic and epidemic cases of Legionnaires' disease.

27 agent of a severe form of pneumonia known as Legionnaires' disease.

28 sative agent of a severe pneumonia, known as Legionnaires' disease.

29 causative agent of a severe pneumonia called Legionnaires' disease.

30 n result in the often fatal pneumonia called Legionnaires' disease.

31 f the severe and potentially fatal pneumonia Legionnaires' disease.

32 agent of a severe form of pneumonia known as Legionnaires' disease.

33 vivo in macrophages and in a mouse model of Legionnaires' disease.

34 hat causes an acute form of pneumonia called Legionnaires' disease.

35 cellular human pathogen that can cause fatal Legionnaires' disease.

36 crophages, causing a severe pneumonia termed Legionnaires' disease.

37 an acute, potentially fatal pneumonia called Legionnaires' disease.

38 tive bacterial pathogen that is the cause of Legionnaires' Disease.

39 lveolar macrophages as a central property of Legionnaires' disease.

40 macrophages and causes the severe pneumonia Legionnaires' disease.

41 an alveolar macrophages and protozoa, causes Legionnaires' disease.

42 50 passengers with Legionnaires' disease (16 confirmed, 34 probable) were i

43 gionella pneumophila, the bacterial agent of Legionnaires' disease, a potentially fatal pneumonia acq

44 The model is applied to outbreaks of Legionnaires' disease, a potentially life-threatening fo

45 onella pneumophila is the causative agent of Legionnaires' disease, a severe pneumonia.

46 tive intracellular parasite and the agent of Legionnaires' disease, acquires iron are largely unexpla

47 We report an outbreak of Legionnaires' disease among cruise ship passengers that

48 intracellular bacterial pathogen that causes Legionnaires' disease, an inflammatory pneumonia.

49 tigations were notable for first identifying Legionnaires disease and Pontiac fever, hantavirus pulmo

50 L. pneumophila is well known as the cause of Legionnaires' disease and a lesser form called Pontiac f

51 tage for colonization of lung tissues during Legionnaires' disease and invasion of amoebas in the env

52 context of the epidemiology of the pneumonia Legionnaires' disease and virulence mechanisms of Leishm

53 tic tests to accurately inform management of Legionnaires' disease, and controlled clinical trials to

54 between Legionella pneumophila, the agent of Legionnaires' disease, and hemin has received little att

55 ding the distribution and natural history of Legionnaires' disease, and inform outbreak investigation

56 nary proliferation in the A/J mouse model of Legionnaires' disease, and the defect is fully complemen

57 ay be a cost-effective method for control of Legionnaires' disease at the municipal level or in indiv

58 During infection, the Legionnaires' disease bacterium, Legionella pneumophila,

59 The Legionnaires' disease bacterium, Legionella pneumophila,

60 The Legionnaires' disease bacterium, Legionella pneumophila,

61 Legionella pneumophila causes Legionnaires' disease by replication in alveolar macroph

62 ila, the Gram-negative bacterium that causes Legionnaires' disease, can be cultured in the laboratory

63 Legionnaires' disease cannot be clinically or radiograph

64 refute suspected links between hospitals and Legionnaires' disease cases.

65 st urinary antigen kits for the detection of Legionnaires' disease caused by organisms other than Leg

66 ila causes a severe form of pneumonia called Legionnaires' disease, characterized by bacterial replic

67 2008 to October 2010, there were 22 cases of Legionnaires' disease compared with 92 during November 2

68 nella pneumophila, the causative organism of Legionnaires' disease, contains a recently discovered no

69 Although uncommon, Legionnaires' disease continues to cause disease outbrea

70 gionella pneumophila, the causative agent of Legionnaires' disease, employs the Dot/Icm T4SS to injec

71 nella pneumophila, the causative organism of Legionnaires' disease, encodes two virulence-associated

72 gionella pneumophila, the causative agent of Legionnaires' disease, expresses a type IVB secretion ap

73 Legionella pneumophila, the primary agent of Legionnaires' disease, flourishes in both natural and ma

74 to measure the increase in case detection of Legionnaires' disease following the introduction of rout

75 pes under conditions mimicking the spread of Legionnaires' disease from environmental niches.

76 We hypothesize that the increase in reported Legionnaires' disease from June 2014 to November 2015 in

77 gionella pneumophila, the causative agent of Legionnaires' disease, grows within macrophages and mani

78 ffect of monochloramine on the occurrence of Legionnaires' disease has never been studied.

79 ver time, the prevalence of legionellosis or Legionnaires' disease has risen, which might indicate a

80 gionella pneumophila, the causative agent of Legionnaires disease, has a biphasic life cycle with a s

81 new diseases have been identified, including Legionnaires' disease, human immunodeficiency virus (HIV

82 sted in the two most relevant host cells for Legionnaires' disease, i.e., amoebae and macrophages.

83 erformance of different diagnostic tests for Legionnaires' disease in a clinical setting where Legion

84 A case of Legionnaires' disease in a hematopoietic stem cell trans

85 likely to be critical for the production of Legionnaires' disease in humans.

86 ella pneumophila is the predominant cause of Legionnaires' disease in the United States and Europe, w

87 After rapid diagnosis of Legionnaires' disease in three passengers by urine antig

88 o 16.2, 95% Cl 2.8-351:7); risk of acquiring Legionnaires' disease increased by 64% (95% Cl 12-140) f

89 gionella pneumophila, the causative agent of Legionnaires disease, infects and replicates within huma

90 umophila, the Gram-negative pathogen causing Legionnaires' disease, infects host cells by hijacking e

91 usative agent of a severe pneumonia known as Legionnaires' disease, intercepts material from host cel

92 gionella pneumophila, the causative agent of Legionnaires' disease, invades and proliferates within a

93 Legionnaires' disease is a potentially lethal pneumonia

94 Legionnaires' disease is a severe form of pneumonia caus

95 Legionnaires' disease is an important cause of community

96 Legionnaires' disease is an important cause of hospital-

97 e ability of Legionella pneumophila to cause Legionnaires' disease is dependent on its capacity to su

98 The hallmark of Legionnaires' disease is intracellular replication of Le

99 In our region, the burden of Legionnaires' disease is much greater than was previousl

100 Legionnaires' disease is not always suspected because of

101 The hallmark of Legionnaires' disease is replication of Legionella pneum

102 nella pneumophila, the causative organism of Legionnaires' disease, is a fresh-water bacterium and in

103 gionella pneumophila, the causative agent of Legionnaires' disease, is a ubiquitous freshwater bacter

104 Legionella pneumophila, the agent of Legionnaires' disease, is an intracellular pathogen of p

105 nella pneumophila, the causative organism of Legionnaires' disease, is one of a small number of bacte

106 gionella pneumophila, the causative agent of Legionnaires' disease, is phagocytosed by alveolar macro

107 usative agent of a severe pneumonia known as Legionnaires' disease, it is likely that most infections

108 Travel-associated outbreaks of legionnaires disease (LD) and combined outbreaks of LD a

109 orphisms in TLR4 influence susceptibility to Legionnaires' disease (LD) by using a case-control study

110 Healthcare-associated Legionnaires' disease (LD) is a preventable pneumonia wi

111 An outbreak of community-acquired Legionnaires' disease (LD) occurred in Providence, R.I.,

112 ping of Lp1 isolates from sporadic cases and Legionnaires' disease (LD) outbreaks deposited into the

113 We investigated 4 cases of legionnaires' disease (LD) reported among workers at an

114 (LP) serogroup-1 (Lp1) is the major cause of Legionnaires' Disease (LD), a life-threatening pulmonary

115 ability of gastrointestinal illness (GI) and Legionnaires'disease (LD) were analyzed in QMRA models u

116 Urine specimens from patients without Legionnaires' disease (n = 33) were negative by both met

117 Two nosocomial cases of Legionnaires' disease occurred in children.

118 ale aerosols containing Legionella bacteria, Legionnaires' disease or Pontiac fever may result.

119 Control of Legionnaires' disease outbreaks relies on rapid ascertai

120 nical relevance of these findings, we tested Legionnaires' disease patient sera for reactivity with t

121 aboratory evidence of infection) or probable Legionnaires' disease (pneumonia of undetermined cause).

122 7%) of 26 urine specimens from patients with Legionnaires' disease positive by the radioimmunoassay k

123 ella pneumophila, the gram-negative agent of Legionnaires' disease, possesses type IV pili and a type

124 Outbreaks of travel-related Legionnaires' disease present a public-health challenge

125 gionella pneumophila, the bacterial agent of legionnaires' disease, replicates intracellularly within

126 Zealand, we compared the number of cases of Legionnaires' disease requiring hospitalization diagnose

127 Legionella pneumophila, the agent of Legionnaires' disease, secretes a siderophore (legiobact

128 Review we outline the global epidemiology of Legionnaires' disease, summarise its diagnosis and manag

129 e more likely to have a reported outbreak of Legionnaires' disease than those that used water with mo

130 The causative agent of Legionnaires' disease, the gamma-proteobacterium Legione

131 onella pneumophila, the etiological agent of Legionnaires' disease, triggers activation of multiple i

132 athogen responsible for the severe pneumonia Legionnaires' disease, uses its dot/icm-encoded type IV

133 ct of inhaled amoebae on the pathogenesis of Legionnaires' disease was investigated in vivo.

134 Legionella pneumophila is the cause of Legionnaires' disease, which is a form of potentially fa

135 onella pneumophila is the causative agent of Legionnaires' disease, which is associated with intracel

136 f of 6 days will identify community-acquired Legionnaires' disease with a positive predictive value a

137 ed to 32 hospitals that had had outbreaks of Legionnaires' disease with the disinfection method for w